Titre

Surgical Resection Versus Transarterial Chemoembolization for Intermediate Stage Hepatocellular Carcinoma (BCLC-B): An Unsolved Question.

Type
lettre à l'éditeur
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Auteur(s)
Labgaa, I.
Auteure/Auteur
Demartines, N.
Auteure/Auteur
Melloul, E.
Auteure/Auteur
Liens vers les personnes
Liens vers les unités
ISSN
1527-3350
Statut éditorial
Publié
Date de publication
2019-02
Volume
69
Numéro
2
Première page
923
Peer-reviewed
Oui
Langue
anglais
Notes
Publication types: Letter ; Comment
Publication Status: ppublish
Résumé
We have read the article of Hyun MH et al. with great interest (1). We commend the authors for this study that tackles a crucial point in the treatment of hepatocellular carcinoma (HCC). There is a critical need to refine and eventually to expand the selection criteria of HCC patients who may benefit from curative therapies such as surgical resection (SR). There is accumulating evidence on improved survival after SR as opposed to transarterial chemoembolization (TACE) in patients with intermediate stage HCC (Barcelona Clinic Liver Cancer Stage B (BCLC-B)), although American (AASLD) and European (EASL) consensus guidelines recommend TACE in this setting (2, 3). This article is protected by copyright. All rights reserved.
Sujets

Carcinoma, Hepatocell...

Chemoembolization, Th...

Hepatectomy

Humans

Liver Neoplasms/surge...

PID Serval
serval:BIB_1275C0764544
DOI
PMID
WOS
Permalien
Open Access
Oui
Date de création
2018-11-07T11:05:59.218Z
Date de création dans IRIS
2025-05-20T17:38:19Z
Fichier(s)
En cours de chargement...
Vignette d'image
Nom

Hepatology - 2018 - Labgaa - Surgical Resection Versus Transarterial Chemoembolization for Intermediate Stage.pdf

Version du manuscrit

published

Taille

62.13 KB

Format

Adobe PDF

PID Serval

serval:BIB_1275C0764544.P001

URN

urn:nbn:ch:serval-BIB_1275C07645448

Somme de contrôle

(MD5):8c67d575ccd48da50fd03a790944396c